These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27138568)

  • 1. The mitochondrial calcium uniporter regulates breast cancer progression via HIF-1α.
    Tosatto A; Sommaggio R; Kummerow C; Bentham RB; Blacker TS; Berecz T; Duchen MR; Rosato A; Bogeski I; Szabadkai G; Rizzuto R; Mammucari C
    EMBO Mol Med; 2016 May; 8(5):569-85. PubMed ID: 27138568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The function of Piezo1 in colon cancer metastasis and its potential regulatory mechanism.
    Sun Y; Li M; Liu G; Zhang X; Zhi L; Zhao J; Wang G
    J Cancer Res Clin Oncol; 2020 May; 146(5):1139-1152. PubMed ID: 32152662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional validation of FDA-approved positive and negative modulators of the mitochondrial calcium uniporter.
    De Mario A; Tosatto A; Hill JM; Kriston-Vizi J; Ketteler R; Vecellio Reane D; Cortopassi G; Szabadkai G; Rizzuto R; Mammucari C
    Cell Rep; 2021 Jun; 35(12):109275. PubMed ID: 34161774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts.
    Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB
    J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance.
    Xiong G; Stewart RL; Chen J; Gao T; Scott TL; Samayoa LM; O'Connor K; Lane AN; Xu R
    Nat Commun; 2018 Oct; 9(1):4456. PubMed ID: 30367042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
    Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
    J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review.
    Liu L; Bai J; Hu L; Jiang D
    Medicine (Baltimore); 2023 Oct; 102(43):e35493. PubMed ID: 37904441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy.
    Liu Q; Guan C; Liu C; Li H; Wu J; Sun C
    Biomed Pharmacother; 2022 Dec; 156():113861. PubMed ID: 36228375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
    Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
    Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial calcium uniporter activity is dispensable for MDA-MB-231 breast carcinoma cell survival.
    Hall DD; Wu Y; Domann FE; Spitz DR; Anderson ME
    PLoS One; 2014; 9(5):e96866. PubMed ID: 24802861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer.
    Li S; Wei Q; Li Q; Zhang B; Xiao Q
    Cancer Biol Ther; 2015; 16(6):866-75. PubMed ID: 25920936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA LINC00649 promotes the growth and metastasis of triple-negative breast cancer by maintaining the stability of HIF-1α through the NF90/NF45 complex.
    Zhang J; Du C; Zhang L; Wang Y; Zhang Y; Li J
    Cell Cycle; 2022 May; 21(10):1034-1047. PubMed ID: 35188449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming.
    Jin J; Qiu S; Wang P; Liang X; Huang F; Wu H; Zhang B; Zhang W; Tian X; Xu R; Shi H; Wu X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):377. PubMed ID: 31455352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets.
    Shah T; Krishnamachary B; Wildes F; Mironchik Y; Kakkad SM; Jacob D; Artemov D; Bhujwalla ZM
    Oncotarget; 2015 Sep; 6(29):28104-19. PubMed ID: 26305551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
    Cui J; Jiang H
    Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression.
    Regan Anderson TM; Peacock DL; Daniel AR; Hubbard GK; Lofgren KA; Girard BJ; Schörg A; Hoogewijs D; Wenger RH; Seagroves TN; Lange CA
    Cancer Res; 2013 Sep; 73(18):5810-20. PubMed ID: 23928995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin C Inhibits Triple-Negative Breast Cancer Metastasis by Affecting the Expression of YAP1 and Synaptopodin 2.
    Gan L; Camarena V; Mustafi S; Wang G
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro.
    Tanaka T; Ikegami Y; Nakazawa H; Kuriyama N; Oki M; Hanai J; Sukhatme VP; Kaneki M
    J Cell Physiol; 2017 Jan; 232(1):192-201. PubMed ID: 27137755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA (lncRNA) metallothionein 1 J, pseudogene (MT1JP) is downregulated in triple-negative breast cancer and upregulates microRNA-138 (miR-138) to downregulate hypoxia-inducible factor-1α (HIF-1α).
    Wang G; Dong Y; Liu H; Ji N; Cao J; Liu A; Tang X; Ren Y
    Bioengineered; 2022 May; 13(5):13718-13727. PubMed ID: 35703312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
    Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN
    Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.